Waverunner Capital Inc.

Waverunner Capital Inc. is a venture capital firm specializes in early-stage, seed/startup, PIPEs, bridge financing, recapitalizations, growth capital and secondary investing limited partner interests investments. It also holds investments in resources,renewable energy in the wind and solar sector; a plant-based wellness company; and consumer-targeted biotechnology venture. It seeks to invest in Europe and North America. It seeks to invest in equity investment between Can$500k($345 million) and Can$1million($694 million) enterprise value between Can$2 million($138 million) and Can$5million($347 million). It makes investments through its own balance sheet and personal capital. The company was formerly known as Chemistree Technology Inc. and changed its name to Waverunner Capital Inc. in June 2024. Waverunner Capital Inc. was founded in 2008 and is based in North Vancouver, Canada.

Waverunner Capital Inc. trades as CHMJF on OTC. The company is classified in Financial Services / Asset Management and reports in USD.

The current profile places the business in Asset Management. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Latest available fiscal data shows $0 of revenue and -$1.00M of net income.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

Waverunner Capital Inc. can be compared against peers such as Atlantica, Inc., China Dongsheng International, Inc., Emerging World Pharma, Inc., KCM Holdings Corporation, Lotus Pharmaceuticals, Inc., One World Ventures, Inc..

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $114,116, beta of 2.90, and return on equity of +100.0%.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

CHMJF currently shows total debt of $444,271 and beta of 2.90. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.waverunnercapital.com

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.